A citation-based method for searching scientific literature

Angus G Jones, Timothy J McDonald, Beverley M Shields, Anita V Hill, Christopher J Hyde, Bridget A Knight, Andrew T Hattersley. Diabetes Care 2016
Times Cited: 77







List of co-cited articles
585 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
23

Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials.
Paolo Pozzilli, Richard D Leslie, Anne L Peters, Raffaella Buzzetti, Sudha S Shankar, Zvonko Milicevic, Imre Pavo, Jeremie Lebrec, Sherry Martin, Nanette C Schloot. Diabetes Obes Metab 2018
19
63



Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
14

High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
Raffaella Buzzetti, Sergio Di Pietro, Andrea Giaccari, Antonio Petrone, Mattia Locatelli, Concetta Suraci, Marco Capizzi, Maria Luisa Arpi, Elena Bazzigaluppi, Francesco Dotta,[...]. Diabetes Care 2007
143
14

Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.
Emma Ahlqvist, Petter Storm, Annemari Käräjämäki, Mats Martinell, Mozhgan Dorkhan, Annelie Carlsson, Petter Vikman, Rashmi B Prasad, Dina Mansour Aly, Peter Almgren,[...]. Lancet Diabetes Endocrinol 2018
606
14

Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, R David Leslie, Xiangbing Wang, Zhiguang Zhou. J Clin Endocrinol Metab 2014
74
13

Interventions for latent autoimmune diabetes (LADA) in adults.
Sinead Brophy, Helen Davies, Sopna Mannan, Huw Brunt, Rhys Williams. Cochrane Database Syst Rev 2011
43
23

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.
Mohammed I Hawa, Hubert Kolb, Nanette Schloot, Huriya Beyan, Stavroula A Paschou, Raffaella Buzzetti, Didac Mauricio, Alberto De Leiva, Knud Yderstraede, Henning Beck-Neilsen,[...]. Diabetes Care 2013
168
12

C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study.
Odd Erik Johansen, Bernhard O Boehm, Valdemar Grill, Peter A Torjesen, Sudipta Bhattacharya, Sanjay Patel, Kristiane Wetzel, Hans-Juergen Woerle. Diabetes Care 2014
41
24

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
12

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars,[...]. Diabetes 1999
363
11

Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
Zhiguang Zhou, Yufei Xiang, Linong Ji, Weiping Jia, Guang Ning, Gan Huang, Lin Yang, Jian Lin, Zhenqi Liu, William A Hagopian,[...]. Diabetes 2013
142
11

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
11

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Steven E Kahn, Steven M Haffner, Mark A Heise, William H Herman, Rury R Holman, Nigel P Jones, Barbara G Kravitz, John M Lachin, M Colleen O'Neill, Bernard Zinman,[...]. N Engl J Med 2006
11

Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).
R Buzzetti, P Pozzilli, R Frederich, N Iqbal, B Hirshberg. Diabetes Metab Res Rev 2016
31
29

The many faces of diabetes: a disease with increasing heterogeneity.
Tiinamaija Tuomi, Nicola Santoro, Sonia Caprio, Mengyin Cai, Jianping Weng, Leif Groop. Lancet 2014
309
10

Genetic cause of hyperglycaemia and response to treatment in diabetes.
Ewan R Pearson, Bryan J Starkey, Roy J Powell, Fiona M Gribble, Penny M Clark, Andrew T Hattersley. Lancet 2003
338
10

GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
Simona Zampetti, Marco Capizzi, Marialuisa Spoletini, Giuseppe Campagna, Gaetano Leto, Laura Cipolloni, Claudio Tiberti, Emanuele Bosi, Alberto Falorni, Raffaella Buzzetti. J Clin Endocrinol Metab 2012
50
16

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
10

Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement.
Ernesto Maddaloni, Nader Lessan, Alia Al Tikriti, Raffaella Buzzetti, Paolo Pozzilli, Maha T Barakat. PLoS One 2015
43
18

Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy.
John M Dennis, Beverley M Shields, Anita V Hill, Bridget A Knight, Timothy J McDonald, Lauren R Rodgers, Michael N Weedon, William E Henley, Naveed Sattar, Rury R Holman,[...]. Diabetes Care 2018
34
23

Adult-onset autoimmune diabetes: current knowledge and implications for management.
Raffaella Buzzetti, Simona Zampetti, Ernesto Maddaloni. Nat Rev Endocrinol 2017
86
10

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
Ewan R Pearson, Isabelle Flechtner, Pål R Njølstad, Maciej T Malecki, Sarah E Flanagan, Brian Larkin, Frances M Ashcroft, Iwar Klimes, Ethel Codner, Violeta Iotova,[...]. N Engl J Med 2006
629
9



Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
9

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.
Michael W Steffes, Shalamar Sibley, Melissa Jackson, William Thomas. Diabetes Care 2003
459
9

Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.
Bernard Zinman, Steven E Kahn, Steven M Haffner, M Colleen O'Neill, Mark A Heise, Martin I Freed. Diabetes 2004
113
9

High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
Simona Zampetti, Giuseppe Campagna, Claudio Tiberti, Marco Songini, Maria Luisa Arpi, Giuseppina De Simone, Efisio Cossu, Lorenzo Cocco, John Osborn, Emanuele Bosi,[...]. Eur J Endocrinol 2014
35
20

Latent autoimmune diabetes in adults (LADA) should be less latent.
S Fourlanos, F Dotta, C J Greenbaum, J P Palmer, O Rolandsson, P G Colman, L C Harrison. Diabetologia 2005
204
9

Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
M Maioli, G M Pes, G Delitala, L Puddu, A Falorni, F Tolu, R Lampis, V Orrù, G Secchi, A M Cicalò,[...]. Eur J Endocrinol 2010
48
14

Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.
Taro Maruyama, Shoichiro Tanaka, Akira Shimada, Osamu Funae, Akira Kasuga, Azuma Kanatsuka, Izumi Takei, Satoru Yamada, Norikazu Harii, Hiroki Shimura,[...]. J Clin Endocrinol Metab 2008
75
9

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
9

LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.
Mohammed Iqbal Hawa, Ana Paula Buchan, Thomas Ola, Chuan Chuan Wun, David A DeMicco, Weihang Bao, D John Betteridge, Paul N Durrington, John H Fuller, H Andrew W Neil,[...]. Diabetes Care 2014
45
13

Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
Lingjiao Liu, Xia Li, Yufei Xiang, Gan Huang, Jian Lin, Lin Yang, Yunjuan Zhao, Zhifang Yang, Can Hou, Yijun Li,[...]. Diabetes Care 2015
53
11

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial.
Kathleen M Dungan, Santiago Tofé Povedano, Thomas Forst, José G González González, Charles Atisso, Whitney Sealls, Jessie L Fahrbach. Lancet 2014
282
7

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
Kaixin Zhou, Celine Bellenguez, Chris C A Spencer, Amanda J Bennett, Ruth L Coleman, Roger Tavendale, Simon A Hawley, Louise A Donnelly, Chris Schofield, Christopher J Groves,[...]. Nat Genet 2011
287
7

Pharmacology, physiology, and mechanisms of incretin hormone action.
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
759
7

The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.
K Y Thong, T J McDonald, A T Hattersley, A D Blann, S Ramtoola, C Duncan, S Carr, K Adamson, A U Nayak, R Khurana,[...]. Diabet Med 2014
11
54

Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment.
R David Leslie, Jerry Palmer, Nanette C Schloot, Ake Lernmark. Diabetologia 2016
91
7


Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Claudio Tiberti, Carla Giordano, Mattia Locatelli, Emanuele Bosi, Gian Franco Bottazzo, Raffaella Buzzetti, Domenico Cucinotta, Aldo Galluzzo, Alberto Falorni, Francesco Dotta. Diabetes 2008
32
18

Use and abuse of HOMA modeling.
Tara M Wallace, Jonathan C Levy, David R Matthews. Diabetes Care 2004
7



GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.
M Desai, C A Cull, V A Horton, M R Christie, E Bonifacio, V Lampasona, P J Bingley, J C Levy, I R Mackay, P Zimmet,[...]. Diabetologia 2007
43
13


Precision diabetes: learning from monogenic diabetes.
Andrew T Hattersley, Kashyap A Patel. Diabetologia 2017
117
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.